Author

Xiangxin Kong

Affiliated Hospital of North Sichuan Medical College

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Aiping LüiD· 1 shared Baisen CheniD· 1 shared Chao ZuoiD· 1 shared Chi Chun WongiD· 1 shared Ding DingiD· 1 shared Hiu Yee KwaniD· 1 shared Hoi Leong Xavier WongiD· 1 shared Hongmei LuiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aiping LüORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Programmable Aptamer-Embedded Circular RNAs for Targeted Antigen-Presenting Cells Immunotherapy

Yu Zhang, Wenxi Wang, Xu Qian, Jian Chen, Ding Ding, Shaoju Gan, Weicheng Yi, Yalin Li, Yaping Deng, Zhongchao Chen, Hongyu Wu, Kedan Gu, Yuji Niu, Juanjuan Zhou, Xiangxin Kong, , Weihong Tan

This paper develops Apt-circRNAs for targeted antigen-presenting cell immunotherapy, showing efficacy in tumors and clinical trials.

bioRxiv · Sep 28, 2025 · PreprintBioengineering

Metabolic modulation of intratumoral cholesterol with gut microbiota for the treatment of colorectal cancer

Jiayan Wu, Yingyao Lai, Jinming Li, Lixiang Zhai, Pallavi Asthana, Lexin Chen, Minting Chen, Baisen Chen, Susma Gurung, Jin Lyu, Yijing Zhang, Lin Tao Lü, Shuojie Huang, Weihong Kuang, Hui Shi, , Hoi Leong Xavier Wong

This paper identifies 4-C-3 as an antitumor metabolite derived from cholesterol by gut microbiota, showing its efficacy in CRC models through dual inhibition of EGFR and KRAS.

bioRxiv · May 2, 2025 · PreprintCancer Biology